Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital

BackgroundThe worldwide dissemination of K. pneumoniae isolates is a significant public health concern, as these organisms possess a unique capacity to acquire genetic elements encoding both resistance and hypervirulence. This study aims to investigate the epidemiological, resistance, and virulence...

Full description

Bibliographic Details
Main Authors: Ping Li, Wan-ying Luo, Tian-Xin Xiang, Ting-xiu Peng, Shuai Luo, Zhi-yong He, Wenjian Liao, Dan-Dan Wei, Peng Liu, La-gen Wan, Wei Zhang, Yang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1182870/full
_version_ 1797821456586899456
author Ping Li
Ping Li
Ping Li
Wan-ying Luo
Wan-ying Luo
Tian-Xin Xiang
Ting-xiu Peng
Ting-xiu Peng
Shuai Luo
Shuai Luo
Zhi-yong He
Zhi-yong He
Wenjian Liao
Dan-Dan Wei
Dan-Dan Wei
Peng Liu
La-gen Wan
Wei Zhang
Wei Zhang
Yang Liu
Yang Liu
author_facet Ping Li
Ping Li
Ping Li
Wan-ying Luo
Wan-ying Luo
Tian-Xin Xiang
Ting-xiu Peng
Ting-xiu Peng
Shuai Luo
Shuai Luo
Zhi-yong He
Zhi-yong He
Wenjian Liao
Dan-Dan Wei
Dan-Dan Wei
Peng Liu
La-gen Wan
Wei Zhang
Wei Zhang
Yang Liu
Yang Liu
author_sort Ping Li
collection DOAJ
description BackgroundThe worldwide dissemination of K. pneumoniae isolates is a significant public health concern, as these organisms possess a unique capacity to acquire genetic elements encoding both resistance and hypervirulence. This study aims to investigate the epidemiological, resistance, and virulence characteristics of K. pneumoniae isolates that carry both virulence plasmids and blaOXA-48-like genes in a tertiary hospital in China.MethodsA total of 217 clinical isolates of carbapenem-resistant K. pneumoniae (CRKP) were collected between April 2020 and March 2022. The antimicrobial susceptibility test was conducted to evaluate the drug resistance profile. All isolates were screened for the presence of genes encoding carbapenemases (blaKPC, blaNDM, blaIMP, blaVIM, and blaOXA-48-like), ESBLs genes (blaCTX-M, blaSHV, blaTEM), and virulence plasmid pLVPK-borne genes (rmpA, rmpA2, iucA, iroB, and peg344) using polymerase chain reaction (PCR) amplification. Clonal lineages were assigned using multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE). The plasmid incompatibility groups were identified using PCR-based replicon typing (PBRT). The transferability of carbapenemase-encoding plasmids and pLVPK-like virulence plasmids was assessed via conjugation. The plasmid location of rmpA2 was determined using S1-Pulsed Field Gel Electrophoresis (S1-PFGE) and southern blotting hybridization. The virulence potential of the isolates was assessed using the string test, capsular serotyping, serum killing assay and a Galleria mellonella larval infection model.ResultsOf the 217 CRKP clinical isolates collected, 23% were identified as carrying blaOXA-48-like genes. All blaOXA-48-like isolates exhibited resistance to commonly used clinical antimicrobial agents, except for ceftazidime/avibactam, colistin, tigecycline, trimethoprim-sulfamethOXAzole, polymyxin B, and nitrofurantoin. The main common OXA-48-like carbapenemase enzymes were found to be blaOXA-181 and blaOXA-232. MLST and PFGE fingerprinting analysis revealed clonal transmission and plasmid transmission. OXA-48-like producing CRKP isolates mainly clustered in K64 ST11 and K47 ST15. Results of the string Test, serum killing assay (in vitro) and Galleria mellonella infection model (in vivo) indicated hypervirulence. PBRT showed that the blaOXA-181 and blaOXA-232 producing hypervirulent carbapenem-resistant Klebsiella pneumoniae (Hv-CRKP) were mainly carried on ColE-type, IncF, and IncX3. Eight clinical isolates of hv-CRKP were identified as carrying three carbapenem-resistant genes (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1). Moreover, Southern blotting hybridization revealed that all eight isolates had a pLVPK-like virulent plasmid (138.9–216.9 kb) with an uneven number and size of plasmid.ConclusionIn our investigation, we have observed the emergence of hv-CRKP carrying blaOXA-48-like genes, which identified two genetic relationships: clonal transmission and plasmid transmission. PBRT analysis showed that these genes were mainly carried on ColE-type, IncF, and IncX3 plasmids. These isolates have been shown to be hypervirulent in vitro and in vivo. Additionally, eight clinical isolates of hv-CRKP were identified as carrying three carbapenem-resistant genes (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and carrying a pLVPK-like virulent plasmid. Hence, our findings highlight the need for further investigation and active surveillance of hypervirulent OXA-48-like producing Hv-CRKP isolates to control their transmission.
first_indexed 2024-03-13T09:52:58Z
format Article
id doaj.art-d5da1c2a634b414eafbc1414f09e24ff
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-03-13T09:52:58Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-d5da1c2a634b414eafbc1414f09e24ff2023-05-24T06:10:02ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-05-011410.3389/fmicb.2023.11828701182870Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospitalPing Li0Ping Li1Ping Li2Wan-ying Luo3Wan-ying Luo4Tian-Xin Xiang5Ting-xiu Peng6Ting-xiu Peng7Shuai Luo8Shuai Luo9Zhi-yong He10Zhi-yong He11Wenjian Liao12Dan-Dan Wei13Dan-Dan Wei14Peng Liu15La-gen Wan16Wei Zhang17Wei Zhang18Yang Liu19Yang Liu20Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaJiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaYichun People's Hospital, Yichun, ChinaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaJiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaJiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaJiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaJiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaDepartment of Clinical Laboratory, Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaNational Regional Center for Respiratory Medicine, China-Japan Friendship Jiang Xi Hospital, Nanchang, Jiangxi, ChinaDepartment of Clinical Laboratory, Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaDepartment of Clinical Laboratory, Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaJiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Clinical Laboratory, Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, ChinaNational Regional Center for Respiratory Medicine, China-Japan Friendship Jiang Xi Hospital, Nanchang, Jiangxi, ChinaBackgroundThe worldwide dissemination of K. pneumoniae isolates is a significant public health concern, as these organisms possess a unique capacity to acquire genetic elements encoding both resistance and hypervirulence. This study aims to investigate the epidemiological, resistance, and virulence characteristics of K. pneumoniae isolates that carry both virulence plasmids and blaOXA-48-like genes in a tertiary hospital in China.MethodsA total of 217 clinical isolates of carbapenem-resistant K. pneumoniae (CRKP) were collected between April 2020 and March 2022. The antimicrobial susceptibility test was conducted to evaluate the drug resistance profile. All isolates were screened for the presence of genes encoding carbapenemases (blaKPC, blaNDM, blaIMP, blaVIM, and blaOXA-48-like), ESBLs genes (blaCTX-M, blaSHV, blaTEM), and virulence plasmid pLVPK-borne genes (rmpA, rmpA2, iucA, iroB, and peg344) using polymerase chain reaction (PCR) amplification. Clonal lineages were assigned using multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE). The plasmid incompatibility groups were identified using PCR-based replicon typing (PBRT). The transferability of carbapenemase-encoding plasmids and pLVPK-like virulence plasmids was assessed via conjugation. The plasmid location of rmpA2 was determined using S1-Pulsed Field Gel Electrophoresis (S1-PFGE) and southern blotting hybridization. The virulence potential of the isolates was assessed using the string test, capsular serotyping, serum killing assay and a Galleria mellonella larval infection model.ResultsOf the 217 CRKP clinical isolates collected, 23% were identified as carrying blaOXA-48-like genes. All blaOXA-48-like isolates exhibited resistance to commonly used clinical antimicrobial agents, except for ceftazidime/avibactam, colistin, tigecycline, trimethoprim-sulfamethOXAzole, polymyxin B, and nitrofurantoin. The main common OXA-48-like carbapenemase enzymes were found to be blaOXA-181 and blaOXA-232. MLST and PFGE fingerprinting analysis revealed clonal transmission and plasmid transmission. OXA-48-like producing CRKP isolates mainly clustered in K64 ST11 and K47 ST15. Results of the string Test, serum killing assay (in vitro) and Galleria mellonella infection model (in vivo) indicated hypervirulence. PBRT showed that the blaOXA-181 and blaOXA-232 producing hypervirulent carbapenem-resistant Klebsiella pneumoniae (Hv-CRKP) were mainly carried on ColE-type, IncF, and IncX3. Eight clinical isolates of hv-CRKP were identified as carrying three carbapenem-resistant genes (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1). Moreover, Southern blotting hybridization revealed that all eight isolates had a pLVPK-like virulent plasmid (138.9–216.9 kb) with an uneven number and size of plasmid.ConclusionIn our investigation, we have observed the emergence of hv-CRKP carrying blaOXA-48-like genes, which identified two genetic relationships: clonal transmission and plasmid transmission. PBRT analysis showed that these genes were mainly carried on ColE-type, IncF, and IncX3 plasmids. These isolates have been shown to be hypervirulent in vitro and in vivo. Additionally, eight clinical isolates of hv-CRKP were identified as carrying three carbapenem-resistant genes (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and carrying a pLVPK-like virulent plasmid. Hence, our findings highlight the need for further investigation and active surveillance of hypervirulent OXA-48-like producing Hv-CRKP isolates to control their transmission.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1182870/fullKlebsiella pneumoniaecarbapenem-resistancemobilized virulence factorsblaOXA geneantimicrobial-resistant genes
spellingShingle Ping Li
Ping Li
Ping Li
Wan-ying Luo
Wan-ying Luo
Tian-Xin Xiang
Ting-xiu Peng
Ting-xiu Peng
Shuai Luo
Shuai Luo
Zhi-yong He
Zhi-yong He
Wenjian Liao
Dan-Dan Wei
Dan-Dan Wei
Peng Liu
La-gen Wan
Wei Zhang
Wei Zhang
Yang Liu
Yang Liu
Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital
Frontiers in Microbiology
Klebsiella pneumoniae
carbapenem-resistance
mobilized virulence factors
blaOXA gene
antimicrobial-resistant genes
title Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital
title_full Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital
title_fullStr Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital
title_full_unstemmed Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital
title_short Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital
title_sort isolation of hv crkp with co production of three carbapenemases blakpc blaoxa 181 or oxa 232 and blandm 1 and a virulence plasmid a study from a chinese tertiary hospital
topic Klebsiella pneumoniae
carbapenem-resistance
mobilized virulence factors
blaOXA gene
antimicrobial-resistant genes
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1182870/full
work_keys_str_mv AT pingli isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT pingli isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT pingli isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT wanyingluo isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT wanyingluo isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT tianxinxiang isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT tingxiupeng isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT tingxiupeng isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT shuailuo isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT shuailuo isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT zhiyonghe isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT zhiyonghe isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT wenjianliao isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT dandanwei isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT dandanwei isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT pengliu isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT lagenwan isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT weizhang isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT weizhang isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT yangliu isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital
AT yangliu isolationofhvcrkpwithcoproductionofthreecarbapenemasesblakpcblaoxa181oroxa232andblandm1andavirulenceplasmidastudyfromachinesetertiaryhospital